North American Non-Knowledge based CDSS Market Trend Analysis to 2018

On purchase of this report, you get next three (3) quarterly updates of the report for free.
The North American non-knowledge based CDSS market was valued at $17 million in 2012, and expected to be $20 million by 2018, at a CAGR of 2.9%.

The report ‘North American Non-Knowledge based CDSS Market forecast, 2012-2018’ analyzes the market by sub-segments integrated CDSS and standalone CDSS. Integrated CDSS accounted for about 70% of the total market. The North American non-knowledge based CDSS market can also be segmented based upon components into hardware, software, and services.
North America is the global leader due to advancement in technology and higher awareness rate amongst patients. North America is a huge market, accounting to 70% of the total market. The U.S. accounted for 90% of the total North American non-knowledge based CDSS market.

Complete report available @ http://www.reportsnreports.com/reports/313725-north-american-non-knowledge-based-cdss-market.html .

Table of Contents
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Non-Knowledge based CDSS-North America, by Applications
4.1 Split by Geography
4.1 Non-Knowledge based CDSS-U.S. by Applications
4.1 Non-Knowledge based CDSS-Canada by Applications
4.1 Non-Knowledge based CDSS-Mexico by Applications
4.2 Non-Knowledge based CDSS-North America-Drug Allergy Alerts

Inquire before buying this report on price $3500 @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=313725 .